セッション詳細

イブニングセミナー3
「Blood biomarkers and early symptomatic Alzheimer's disease」

2026年11月13日(金) 18:05 〜 18:55
第4会場(つくば国際会議場 2F 中会議室201)
座長:池内 健(新潟大学脳研究所附属生命科学研究リソース研究センター)
共催:日本イーライリリー株式会社 研究開発・メディカルアフェアーズ統括本部

【概要】Plasma p-tau217 and the p-tau217/Aβ42 ratio detect Alzheimer’s pathology with accuracy approaching CSF, but the interpretation differs compared with CSF and PET. This talk covers these blood biomarkers for Alzheimer’s disease, the rationale for a two-cutoff approach that could limit confirmatory testing to the intermediate zone, and how to handle intermediate results. It also presents the updated Alzheimer’s Association clinical practice guideline and the gap in diagnostic accuracy between memory clinics and primary care, where most patients are first assessed.

[ES3]Blood biomarkers and early symptomatic Alzheimer's disease

Sebastian Palmqvist (Skåne University Hospital/Lund University)